| Product NDC: | 68016-119 |
| Proprietary Name: | Fexofenadine HCl |
| Non Proprietary Name: | Fexofenadine HCl |
| Active Ingredient(s): | 180 mg/1 & nbsp; Fexofenadine HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68016-119 |
| Labeler Name: | Chain Drug Consortium, LLC (Premier Value) |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA079112 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120618 |
| Package NDC: | 68016-119-01 |
| Package Description: | 1 BOTTLE in 1 BOX (68016-119-01) > 45 TABLET in 1 BOTTLE |
| NDC Code | 68016-119-01 |
| Proprietary Name | Fexofenadine HCl |
| Package Description | 1 BOTTLE in 1 BOX (68016-119-01) > 45 TABLET in 1 BOTTLE |
| Product NDC | 68016-119 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Fexofenadine HCl |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120618 |
| Marketing Category Name | ANDA |
| Labeler Name | Chain Drug Consortium, LLC (Premier Value) |
| Substance Name | FEXOFENADINE HYDROCHLORIDE |
| Strength Number | 180 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |